Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2020

11.05.2020 | Epidemiology

Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and mammographic features

verfasst von: Suélène Georgina Dofara, Sue-Ling Chang, Caroline Diorio

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Matrix metalloproteinases (MMP)-2 and -9 may play an important role in adipogenesis and carcinogenesis. We investigated whether some polymorphisms located in these genes are associated with body adiposity and mammographic breast density, which are risk factors for breast cancer.

Methods

Our study population included 731 premenopausal women. Multivariate generalized linear models were used to evaluate the association of polymorphisms rs243865 in MMP-2 and rs3918242, rs17576, rs2250889 and rs2274756 in MMP-9 with anthropometric factors that refer to adiposity and mammographic features (percent density, dense area and non-dense area) measured by computer-assisted method.

Results

The number of copies of rs243865 T allele in MMP-2 was associated with increased means of anthropometric factors (ptrend < 0.05 for all except waist-to-hip ratio). The same allele of rs243865 was associated with decreased mean percent density (ptrend = 0.036) and increased mean non-dense area (ptrend = 0.031) when adjusted for potential confounders, but these associations were attenuated when further adjusted for adiposity.

Conclusion

These findings suggest that the relation between rs243865 in MMP-2 and mammographic features could be mediated by adiposity.
Literatur
1.
Zurück zum Zitat Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25(1):9–34PubMedCrossRef Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25(1):9–34PubMedCrossRef
2.
Zurück zum Zitat Manicone AM, McGuire JK (2008) Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19(1):34–41CrossRefPubMed Manicone AM, McGuire JK (2008) Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19(1):34–41CrossRefPubMed
3.
Zurück zum Zitat Vu TH et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3):411–422PubMedPubMedCentralCrossRef Vu TH et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3):411–422PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Bouloumié A et al (2001) Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50(9):2080–2086PubMedCrossRef Bouloumié A et al (2001) Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50(9):2080–2086PubMedCrossRef
5.
Zurück zum Zitat Derosa G et al (2008) Matrix metalloproteinase-2 and-9 levels in obese patients. Endothelium 15(4):219–224PubMedCrossRef Derosa G et al (2008) Matrix metalloproteinase-2 and-9 levels in obese patients. Endothelium 15(4):219–224PubMedCrossRef
6.
Zurück zum Zitat Belo VA et al (2009) Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents. Clin Biochem 42(10–11):984–990PubMedCrossRef Belo VA et al (2009) Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents. Clin Biochem 42(10–11):984–990PubMedCrossRef
7.
Zurück zum Zitat Andrade VL et al (2012) Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women. Clin Biochem 45(6):412–415PubMedCrossRef Andrade VL et al (2012) Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women. Clin Biochem 45(6):412–415PubMedCrossRef
9.
Zurück zum Zitat Belo VA et al (2013) Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity. Mol Biol Rep 40(3):2697–2704PubMedCrossRef Belo VA et al (2013) Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity. Mol Biol Rep 40(3):2697–2704PubMedCrossRef
10.
Zurück zum Zitat Andrade VL et al (2012) Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity. DNA Cell Biol 31(6):1054–1057PubMedCrossRef Andrade VL et al (2012) Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity. DNA Cell Biol 31(6):1054–1057PubMedCrossRef
11.
Zurück zum Zitat Belo V et al (2012) Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children. Int J Obes 36(1):69CrossRef Belo V et al (2012) Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children. Int J Obes 36(1):69CrossRef
13.
Zurück zum Zitat O’Reilly MS et al (1999) Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem 274(41):29568–29571PubMedCrossRef O’Reilly MS et al (1999) Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem 274(41):29568–29571PubMedCrossRef
14.
Zurück zum Zitat Boyd N et al (2018) The origins of breast cancer associated with mammographic density: a testable biological hypothesis. Breast Cancer Res 20(1):17PubMedPubMedCentralCrossRef Boyd N et al (2018) The origins of breast cancer associated with mammographic density: a testable biological hypothesis. Breast Cancer Res 20(1):17PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Paszek MJ, Weaver VM (2004) The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia 9(4):325–342PubMedCrossRef Paszek MJ, Weaver VM (2004) The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia 9(4):325–342PubMedCrossRef
16.
17.
Zurück zum Zitat Somiari SB et al (2006) Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 119(6):1403–1411PubMedCrossRef Somiari SB et al (2006) Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 119(6):1403–1411PubMedCrossRef
18.
Zurück zum Zitat Wu ZS et al (2008) Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer 122(9):2050–2056PubMedCrossRef Wu ZS et al (2008) Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer 122(9):2050–2056PubMedCrossRef
19.
Zurück zum Zitat Patel S et al (2011) Role of serum matrix metalloproteinase-2 and-9 to predict breast cancer progression. Clin Biochem 44(10–11):869–872PubMedCrossRef Patel S et al (2011) Role of serum matrix metalloproteinase-2 and-9 to predict breast cancer progression. Clin Biochem 44(10–11):869–872PubMedCrossRef
20.
Zurück zum Zitat Somiari SB et al (2006) Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett 233(1):98–107PubMedCrossRef Somiari SB et al (2006) Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett 233(1):98–107PubMedCrossRef
21.
22.
Zurück zum Zitat Sheen-Chen S-M et al (2001) Serum levels of matrix metalloproteinase 2 in patients with breast cancer. Cancer Lett 173(1):79–82PubMedCrossRef Sheen-Chen S-M et al (2001) Serum levels of matrix metalloproteinase 2 in patients with breast cancer. Cancer Lett 173(1):79–82PubMedCrossRef
23.
Zurück zum Zitat Zhou Y et al (2004) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25(3):399–404PubMedCrossRef Zhou Y et al (2004) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25(3):399–404PubMedCrossRef
24.
Zurück zum Zitat Néjima DB et al (2015) Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study. Tumor Biol 36(5):3815–3822CrossRef Néjima DB et al (2015) Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study. Tumor Biol 36(5):3815–3822CrossRef
25.
Zurück zum Zitat Delgado-Enciso I et al (2008) Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecol Obstet Investig 65(1):68–72CrossRef Delgado-Enciso I et al (2008) Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecol Obstet Investig 65(1):68–72CrossRef
26.
Zurück zum Zitat Saeed HM et al (2013) Matrix metalloproteinase-2 C (-1306) T promoter polymorphism and breast cancer risk in the Saudi population. Acta Biochim Pol 60(3):405–409PubMedCrossRef Saeed HM et al (2013) Matrix metalloproteinase-2 C (-1306) T promoter polymorphism and breast cancer risk in the Saudi population. Acta Biochim Pol 60(3):405–409PubMedCrossRef
27.
Zurück zum Zitat Lei H et al (2007) Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat 103(1):61–69PubMedCrossRef Lei H et al (2007) Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat 103(1):61–69PubMedCrossRef
28.
Zurück zum Zitat Roehe AV et al (2007) Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results. Breast Cancer Res Treat 102(1):123–124PubMedCrossRef Roehe AV et al (2007) Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results. Breast Cancer Res Treat 102(1):123–124PubMedCrossRef
29.
Zurück zum Zitat Beeghly-Fadiel A et al (2009) Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility. Cancer Epidemiol Prev Biomarkers 18(6):1770–1776CrossRef Beeghly-Fadiel A et al (2009) Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility. Cancer Epidemiol Prev Biomarkers 18(6):1770–1776CrossRef
30.
Zurück zum Zitat Zagouri F et al (2013) MMP-2 −1306C%3eT polymorphism in breast cancer: a case–control study in a South European population. Mol Biol Reports 40(8):5035–5040CrossRef Zagouri F et al (2013) MMP-2 −1306C%3eT polymorphism in breast cancer: a case–control study in a South European population. Mol Biol Reports 40(8):5035–5040CrossRef
31.
Zurück zum Zitat Slattery ML et al (2013) Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS ONE 8(5):e63165PubMedPubMedCentralCrossRef Slattery ML et al (2013) Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS ONE 8(5):e63165PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Beeghly-Fadiel A et al (2011) MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Breast Cancer Res Treat 126(2):507–513PubMedCrossRef Beeghly-Fadiel A et al (2011) MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Breast Cancer Res Treat 126(2):507–513PubMedCrossRef
33.
34.
Zurück zum Zitat Chahil JK et al (2015) Genetic polymorphisms associated with breast cancer in Malaysian cohort. Indian J Clin Biochem 30(2):134–139PubMedCrossRef Chahil JK et al (2015) Genetic polymorphisms associated with breast cancer in Malaysian cohort. Indian J Clin Biochem 30(2):134–139PubMedCrossRef
35.
Zurück zum Zitat Rahimi Z, Yari K, Rahimi Z (2015) Matrix metalloproteinase-9-1562T allele and its combination with MMP-2-735 C allele are risk factors for breast cancer. Asian Pac J Cancer Prev 16(3):1175–1179PubMedCrossRef Rahimi Z, Yari K, Rahimi Z (2015) Matrix metalloproteinase-9-1562T allele and its combination with MMP-2-735 C allele are risk factors for breast cancer. Asian Pac J Cancer Prev 16(3):1175–1179PubMedCrossRef
36.
Zurück zum Zitat Huo C et al (2014) Mammographic density—a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat 144(3):479–502PubMedCrossRef Huo C et al (2014) Mammographic density—a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat 144(3):479–502PubMedCrossRef
39.
Zurück zum Zitat Diorio C et al (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Prev Biomarkers 14(5):1065–1073CrossRef Diorio C et al (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Prev Biomarkers 14(5):1065–1073CrossRef
40.
Zurück zum Zitat Diorio C et al (2008) Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Prev Biomarkers 17(4):880–888CrossRef Diorio C et al (2008) Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Prev Biomarkers 17(4):880–888CrossRef
41.
Zurück zum Zitat Habel AF et al (2019) Common matrix metalloproteinase-2 gene variants and altered susceptibility to breast cancer and associated features in Tunisian women. Tumor Biol 41(4):1010428319845749CrossRef Habel AF et al (2019) Common matrix metalloproteinase-2 gene variants and altered susceptibility to breast cancer and associated features in Tunisian women. Tumor Biol 41(4):1010428319845749CrossRef
42.
Zurück zum Zitat Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69(3):562–573PubMedCrossRef Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69(3):562–573PubMedCrossRef
43.
Zurück zum Zitat Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene role of sp1 in allele-specific transcriptional regulation. J Biol Chem 276(10):7549–7558PubMedCrossRef Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene role of sp1 in allele-specific transcriptional regulation. J Biol Chem 276(10):7549–7558PubMedCrossRef
44.
Zurück zum Zitat Chiranjeevi P et al (2014) Gelatinase B (−1562C/T) polymorphism in tumor progression and invasion of breast cancer. Tumor Biol 35(2):1351–1356CrossRef Chiranjeevi P et al (2014) Gelatinase B (−1562C/T) polymorphism in tumor progression and invasion of breast cancer. Tumor Biol 35(2):1351–1356CrossRef
45.
Zurück zum Zitat Hovhannisyan G et al (2009) Differences in measured mammographic density in the menstrual cycle. Cancer Epidemiol Prev Biomarkers 18(7):1993–1999CrossRef Hovhannisyan G et al (2009) Differences in measured mammographic density in the menstrual cycle. Cancer Epidemiol Prev Biomarkers 18(7):1993–1999CrossRef
46.
Zurück zum Zitat Zhang B et al (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99(14):1788–1794PubMedCrossRef Zhang B et al (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99(14):1788–1794PubMedCrossRef
47.
Zurück zum Zitat Tesfaigzi Y et al (2006) Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chronic Obstruct Pulm Dis 1(3):267 Tesfaigzi Y et al (2006) Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chronic Obstruct Pulm Dis 1(3):267
Metadaten
Titel
Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and mammographic features
verfasst von
Suélène Georgina Dofara
Sue-Ling Chang
Caroline Diorio
Publikationsdatum
11.05.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05651-0

Weitere Artikel der Ausgabe 1/2020

Breast Cancer Research and Treatment 1/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.